147118-35-2,
Methyl (3R)-3-(tert-butyldimethylsilyloxy)-5-oxo-6-triphenylphosphoranylidenehexanoate,
Methyl (3R)-3-(tert-butyldimethylsilyloxy)-5-oxo-6-triphenylphosphoranylidene hexanoate,
(R)-Methyl 3-((tert-butyldimethylsilyl)oxy)-5-oxo-6-(triphenylphosphoranylidene)hexanoate,
AK-50690,
PubChem19645,
C31H39O4PSi,
SCHEMBL2345036,
Jsp002732,
CTK4C5262,
KS-00000GJP,
BCP10932,
Hexanoic acid,3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-5-oxo-6-(triphenylphosphoranylidene)-,methyl ester, (3R)-,
MFCD09753068,
AKOS015896175,
ZINC169744991,
AM84433,
LS30271,
RL01856,
AS-15931,
Hexanoic acid, 3-[[(1,1-dimethylethyl)dimethylsilyl]oxy]-5-oxo-6-(triphenylphosphoranylidene)-, methyl ester, (3R)-,
R420,
SC-18006,
AB0018149,
AX8137798,
DB-038002,
FT-0082640,
FT-0650585,
ST24026457,
K-4693,
118M352,
I06-1684,
J-521706,
Methyl(3R)-3-(tert-butyldimethylsilyloxy)-5-oxo-6-,
(3R)-3-(tert-butyldimethylsilyloxy)-5-oxo-6-triphenylphosphoranylidenehexanoate methyl ester,
Methyl (3R)-3-(tert-butyldimethylsilyloxy)-5-oxo-6-triphenylphosphor anylidenehexanoate,
Methyl (3R)-3-[tert-Butyl(dimethyl)silyl]oxy-5-oxo-6-(triphenylphosphanylidene)hexanoate,
Methyl(3R)-3-(tert-butyldimethylsilyloxy)-5-oxo-6-triphenylphosphoranylidenehexanoate,
(R)-3-[(tert-Butyldimethylsilyl)oxy]-6-(triphenylphosphoranylidene)-5-oxohexanoic acid methyl ester,
METHYL (3R)-3-(TERT-BUTYLDIMETHYL SILYLOXY)-5-OXO-6-TRIPHENYL PHOSPHORANYLIDENE HEXANOATE (J6),
methyl (3R)-3-[tert-butyl(dimethyl)silyl]oxy-5-oxo-6-(triphenyl-?^{5}-phosphanylidene)hexanoate,
LKFANOWXMJEZDI-AREMUKBSSA-N,
ACN-048313,
CB11272,
CS-O-31960,
CID10007313,
Methyl -3- -5-oxo-6-triphenylphosphoranylidenehexanoate,
Methyl (3R)-3-(dimethyl-tert-butyl-silyl)oxy-5-oxo-6-triphenylphosphoranylidene-hexanoate,
Methyl(3R)-3-(tert-butyldimethylsilyloxy)-5-oxo-6-triphenylphosphoranylidene hexanoate,
Rosuvastatin intermediate;Methyl (3R)-3-(tert-butyldimethylsilyloxy)-5-oxo-6-triphenylphosphoranylidene hexanate,